Karl Agger

5.8k citations
25 papers · 4.4k indexed · 3 hit papers · h-index 19
Topics
Epigenetics and DNA Methylation (20 papers)Cancer-related gene regulation (10 papers)Histone Deacetylase Inhibitors Research (8 papers)

In The Last Decade

Karl Agger

24 papers receiving 4.3k citations

Hit Papers

UTX and JMJD3 are histone H3K27 demethylases involved in ...20062026201220192007200620082505007501000

Peers

Karl Agger
Comparison fields: 5 of 111
  • Molecular Biology 3.9k
  • Genetics 551
  • Cancer Research 484
  • Oncology 328
  • Immunology 246
Replace Liangjun Wang with:
Liangjun Wang Taiwan
Dana J. Huebert United States
Yu-ichi Tsukada Japan
Eveline J. Steine United States
Marjorie Brand Canada
Aleyde Van Eynde Belgium
Alex Meissner United States
Lluís Morey United States
Alexandre Wagschal France
Francesco Neri Italy
Karl Agger relative to Liangjun Wang Taiwan Liangjun Wang's profile →
Citations per field
00.5×1.5×
Liangjun Wang · 1×
Citations per year

Countries citing papers authored by Karl Agger

Since Specialization
Citations

This map shows the geographic impact of Karl Agger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Agger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Agger more than expected).

Fields of papers citing papers by Karl Agger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Agger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Agger. The network helps show where Karl Agger may publish in the future.

Co-authorship network of co-authors of Karl Agger

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Agger. A scholar is included among the top collaborators of Karl Agger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Agger. Karl Agger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 1
4 2
5 19
6 84
7 187
8 58
9 359
10 72
11 333
12 244
13 36
14
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and diseasebreakdown →
521
15 13
16 416
17
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and developmentbreakdown →
1027
18
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3breakdown →
568
19 96
20 35

About Karl Agger

Karl Agger is a scholar working on Aging, Molecular Biology and Genetics, having authored 25 papers that have together received 4.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (20 papers), Cancer-related gene regulation (10 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Molecular Biology (3.9k citations), Aging (91 citations) and Cancer Research (484 citations). Karl Agger has collaborated with scholars based in Denmark, Italy and United Kingdom. Frequent co-authors include Kristian Helin, Paul A. Cloos, Jens Peter Christensen, Jesper Frank Christensen, Juri Rappsilber, Diego Pasini, Klaus Hansen, Simon Rose, Anna Elisabetta Salcini and Jonas W. Højfeldt. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026